MAP3K5 and Ewing sarcoma: Taken together, our data suggest that GSTM4 binds to ASK1 and inhibits JNK activation and apoptosis induced by etoposide, thus increasing resistance of Ewing sarcoma cells to this commonly used cancer therapeutic agent.